Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.
Related Posts
Dr. Reddy’s launches nivolumab biosimilar in India
Dr Reddy’s Laboratories has taken a significant step in cancer care with the introduction of NIVORZ, a biosimilar of nivolumab. Designed to enhance immune response against a variety of cancers, this new treatment has received approval from the DCGI for twelve specific indications. By making this intravenous therapy available, Dr Reddy’s aims to broaden access…
Sebi proposes wider pool of MII board candidates, SOP for key officials
Sebi has proposed governance reforms for market infrastructure institutions, including relaxed director eligibility rules and standardised requirements for four key management roles. The proposals aim to widen access to expertise while strengthening technology, cybersecurity, compliance and risk management across MIIs.
Form 8K SENTIENT BRANDS HOLDINGS INC. For: 14 August
Form 8K SENTIENT BRANDS HOLDINGS INC. For: 14 August